Skip to main content
Premium Trial:

Request an Annual Quote

Protagen, Mikrogen to Co-Develop Infectious Disease Diagnostics


By Justin Petrone

Protagen has partnered with Mikrogen to develop infectious disease tests based on Protagen's UNIarray protein chip platform.

The German firms said this week that they have conducted a feasibility study for identifying autoantibody signatures in infectious diseases that may be useful for future diagnostics.

Peter Schulz-Knappe, chief scientific officer and executive vice president of diagnostics at Protagen, said in a statement that the companies were "able to show that infection-specific reactions of the immune system are accompanied by the generation of specific autoantibodies" which he deemed "very useful" for the company's joint diagnostic program.

"The cooperation with Protagen secures Mikrogen the access to an important and novel technology platform," said Erwin Soutschek, co-founder and managing director of Neuried-based Mikrogen, in a statement. He added that the firms will jointly develop and market marker panels for differential diagnosis of relevant infectious diseases.

Dortmund-based Protagen has positioned its UNIarray platform for the development of serum-based diagnostics. The company has ongoing development programs for prostate cancer and multiple sclerosis tests. Protagen also has research programs in neurodegenerative diseases, including Parkinson and Alzheimer's, and colon, breast, pancreatic, and ovarian cancers. The firm has also launched a UNIchip line of protein microarrays for the development of antibodies.

Mikrogen offers a menu of tests for bacterial, parasitic, autoimmune, and viral diseases that are run on the Luminex xMAP platform, in PCR systems, and in enzyme-linked immunosorbent assays.

Financial and other terms of the agreement were not disclosed.

The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.